Date published: 2025-9-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

Sodium tetradecyl sulfate (CAS 139-88-8)

0.0(0)
Write a reviewAsk a question

Datasheets
CAS Number:
139-88-8
Molecular Weight:
316.43
Molecular Formula:
C14H29NaO4S
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Sodium tetradecyl sulfate is a synthetic anionic surfactant known for its robust surface-active properties, primarily utilized in non-medical contexts such as the manufacturing of detergents, emulsifiers, and wetting agents in various industries including textiles and cosmetics. The molecule consists of a sulfate group linked to a tetradecyl (14-carbon) chain, which imparts its ability to lower the surface tension between liquids or between a liquid and a solid, enhancing the mixture′s stability and homogeneity. In research, sodium tetradecyl sulfate is extensively employed to investigate the behavior of surfactants in solution, focusing on phenomena such as micelle formation, solubilization, and the dynamics of critical micelle concentration. These studies are pivotal for the chemical industry in optimizing surfactant systems for specific applications, ranging from improving the efficacy of cleaning products to developing advanced materials for industrial use. Additionally, its impact on the stability of emulsions informs the creation of more effective and sustainable industrial lubricants and supports innovations in the stabilization of dispersions critical for manufacturing processes. Through these applications, sodium tetradecyl sulfate not only serves practical industrial needs but also enriches the scientific understanding of surfactant chemistry.


Sodium tetradecyl sulfate (CAS 139-88-8) References

  1. Percutaneous sclerotherapy for head and neck lymphatic malformations in neonates and infants ≤12 months of age.  |  Caton, MT., et al. 2023. J Neurointerv Surg. 15: 1242-1246. PMID: 36414388
  2. Interventions For the Treatment of Lower Limb Telangiectasias and Reticular Veins: A Systematic Review and Network Meta-Analysis.  |  Bontinis, V., et al. 2023. Eur J Vasc Endovasc Surg. 66: 560-576. PMID: 37209995
  3. Scattered Musculoskeletal Venous Malformations in Children: A Rare Report on Clinical Evaluation and Sclerotherapy with Adjunctive Stasis of Efflux.  |  Palo, N., et al. 2023. J Orthop Case Rep. 13: 110-115. PMID: 37521391
  4. Sclerotherapy off the Lower Extremities: A Single-Center Retrospective Study of Veins Treated on the Dorsal Hands and Chest.  |  Verma, KK., et al. 2023. Dermatol Surg. 49: 1012-1016. PMID: 37606885
  5. Usefulness of antegrade foam sclerotherapy for portal hypertensive variceal bleeding.  |  Park, GW., et al. 2023. Diagn Interv Radiol. 29: 826-831. PMID: 37745308
  6. Usefulness of a Low-Dose Sclerosing Agent for the Treatment of Vascular Lesions in the Tongue.  |  Lim, T., et al. 2023. Cureus. 15: e45323. PMID: 37849611
  7. Early Results of Mechanochemical Ablation by Flebogrif and Radiofrequency Ablation in Treating Primary Varicose Veins of Lower Limb.  |  Razaque, A., et al. 2023. Cureus. 15: e45874. PMID: 37885503
  8. Whole-lesion assessment of volume and signal changes after sclerotherapy of extremity venous malformations.  |  Khalil, A., et al. 2024. Eur J Radiol. 174: 111397. PMID: 38452733
  9. Occupational contact dermatitis caused by sodium tetradecyl sulfate in a healthcare worker: A case report.  |  Yu, JE., et al. 2024. SAGE Open Med Case Rep. 12: 2050313X241237604. PMID: 38463449
  10. Intralesional sclerotherapy for angiokeratoma of Fordyce: A case report.  |  Velusamy, B., et al. 2024. SAGE Open Med Case Rep. 12: 2050313X241260492. PMID: 38868664

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Sodium tetradecyl sulfate, 500 ml

sc-507270
500 ml
$1250.00